CRO老大内部重大重组,CXO进入下半场!

盖德视界
Mar 06

CXO的上半场是时代给予的做大做强的机遇,下半场是巨头的较量和细分领域的深耕细作。对于绝大部分业内企业来说,延链扩张已是过去式,时代的节奏或许正精准踩在“向内运营盘整、高效精耕,打通内生增长路径”上。临床CRO老大,内部重大重组落地Guide View据方达控股公告,其收购上海观合医药科技股份100%股权,系列交割已于2026年3月3日作实。交割后,目标公司已成为公司全资附属公司,财务业绩将综合...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10